Does TOCILIZUMAB-AAZG Cause Agranulocytosis? 5 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Agranulocytosis have been filed in association with TOCILIZUMAB-AAZG. This represents 3.2% of all adverse event reports for TOCILIZUMAB-AAZG.
5
Reports of Agranulocytosis with TOCILIZUMAB-AAZG
3.2%
of all TOCILIZUMAB-AAZG reports
0
Deaths
2
Hospitalizations
How Dangerous Is Agranulocytosis From TOCILIZUMAB-AAZG?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB-AAZG. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB-AAZG Cause?
Product substitution issue (18)
Urticaria (17)
Pruritus (16)
Anaphylactic reaction (11)
Headache (10)
Rash (9)
Drug ineffective (8)
Dyspnoea (8)
Fatigue (6)
Hypersensitivity (6)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which TOCILIZUMAB-AAZG Alternatives Have Lower Agranulocytosis Risk?
TOCILIZUMAB-AAZG vs TOCOPHEROL
TOCILIZUMAB-AAZG vs TOFACITINIB
TOCILIZUMAB-AAZG vs TOFERSEN
TOCILIZUMAB-AAZG vs TOLNAFTATE
TOCILIZUMAB-AAZG vs TOLODODEKIN ALFA